BE903483A - Nouvelles formulations galeniques a base de bromocriptine - Google Patents

Nouvelles formulations galeniques a base de bromocriptine

Info

Publication number
BE903483A
BE903483A BE1/011361A BE1011361A BE903483A BE 903483 A BE903483 A BE 903483A BE 1/011361 A BE1/011361 A BE 1/011361A BE 1011361 A BE1011361 A BE 1011361A BE 903483 A BE903483 A BE 903483A
Authority
BE
Belgium
Prior art keywords
bromocriptin
formulations based
galenic formulations
new galenic
lyophylisate
Prior art date
Application number
BE1/011361A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE903483A publication Critical patent/BE903483A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention a pour objet un lyophylisat comprenant la bromocriptine ou un sel d'addition d'acide de ce composé comme substance active, ledit lyophylisat étant capable de reconstitution dans un véhicule isotonique pour donner une formulation stable appropriée pour l'instillation oculaire.
BE1/011361A 1984-10-24 1985-10-21 Nouvelles formulations galeniques a base de bromocriptine BE903483A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426922A GB8426922D0 (en) 1984-10-24 1984-10-24 Galenic formulation

Publications (1)

Publication Number Publication Date
BE903483A true BE903483A (fr) 1986-04-21

Family

ID=10568697

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011361A BE903483A (fr) 1984-10-24 1985-10-21 Nouvelles formulations galeniques a base de bromocriptine

Country Status (15)

Country Link
US (1) US4654345A (fr)
JP (1) JPS61103825A (fr)
AU (1) AU4892885A (fr)
BE (1) BE903483A (fr)
DE (1) DE3536560A1 (fr)
DK (1) DK484785A (fr)
FR (1) FR2571962A1 (fr)
GB (2) GB8426922D0 (fr)
GR (1) GR852545B (fr)
IL (1) IL76781A0 (fr)
IT (1) IT1237360B (fr)
NL (1) NL8502805A (fr)
PT (1) PT81352B (fr)
SE (1) SE8504976L (fr)
ZA (1) ZA858184B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
CA2030174C (fr) * 1990-01-10 1996-12-24 Anthony H. Cincotta Procede pour la reduction a long terme des reserves lipidiques, de l'insulinoresistance, de l'hyperinsulinemie et de l'hypoglycemie chez les vertebres
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
FR2680106B1 (fr) * 1991-08-09 1994-03-11 Corbiere Gerome Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
WO1996011672A1 (fr) * 1994-10-13 1996-04-25 Wakamoto Pharmaceutical Co., Ltd. Preparation lyophilisee permettant d'obtenir une composition pharmaceutique a base d'eau se transformant de maniere reversible en gel sous l'effet de la chaleur
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
US20070275955A1 (en) * 1997-07-31 2007-11-29 Ed. Geistlich Soehne Ag Method of treating tumors
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US8304390B2 (en) 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US8030301B2 (en) 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US7345039B2 (en) 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US6821968B2 (en) 2001-09-26 2004-11-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Stable taurolidine electrolyte solutions
CN120713906A (zh) 2016-04-20 2025-09-30 维罗技术有限责任公司 用于治疗代谢失调的组合物和方法
PL3697418T3 (pl) 2017-10-18 2025-02-03 Veroscience Llc Polepszone preparaty bromokryptyny
PL430675A1 (pl) * 2019-07-23 2021-01-25 Osęka Maciej Bromokryptyna do zastosowania w leczeniu chorób oczu związanych z podwyższonym poziomem śródbłonkowego czynnika wzrostu naczyń (VEGF) oraz kompozycja farmaceutyczna zawierająca bromokryptynę
CA3149877A1 (fr) 2019-09-23 2021-04-01 Anthony H. Cincotta Methode d'induction de regression tumorale

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637967B2 (fr) * 1973-05-17 1981-09-03
CH601321A5 (fr) * 1975-01-06 1978-07-14 Sandoz Ag
US4039662A (en) * 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
YU40533B (en) * 1978-09-04 1986-02-28 Lek Tovarna Farmacevtskih Process for preparing 2-bromoergosinine
SE442265B (sv) * 1978-12-21 1985-12-16 Sandoz Ag Fast, enteral-overdragen komposition i enhetsform for oral tillforsel innehallande en ergotalkaloid
US4283393A (en) * 1979-03-13 1981-08-11 Merck & Co., Inc. Topical application of interferon inducers
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
CA1141663A (fr) * 1979-09-06 1983-02-22 Yukihisa Ishii Solution ophtalmique de restutition de la pression intra-oculaire
GB2058746A (en) * 1979-09-20 1981-04-15 Erba Farmitalia 6,7-Secoergolines
DE3033898A1 (de) * 1980-09-09 1982-04-22 Dr. Thilo & Co GmbH, 8021 Sauerlach Arzneimittel zur lokalen behandlung des glaukoms
BE890369A (fr) * 1980-09-18 1982-03-16 Sandoz Sa Nouveaux medicaments a base d'inhibiteurs de la secretion de la prolactine pour le traitement de l'arteriosclerose
US4486416A (en) * 1981-03-02 1984-12-04 Soll David B Protection of human and animal cells subject to exposure to trauma

Also Published As

Publication number Publication date
US4654345A (en) 1987-03-31
JPS61103825A (ja) 1986-05-22
GB8426922D0 (en) 1984-11-28
IL76781A0 (en) 1986-02-28
DK484785A (da) 1986-04-25
GB2165752A (en) 1986-04-23
GB8525947D0 (en) 1985-11-27
GR852545B (fr) 1986-02-18
IT8548703A0 (it) 1985-10-23
IT1237360B (it) 1993-05-31
PT81352A (en) 1985-11-01
SE8504976D0 (sv) 1985-10-22
AU4892885A (en) 1986-07-17
DK484785D0 (da) 1985-10-22
SE8504976L (sv) 1986-04-25
NL8502805A (nl) 1986-05-16
PT81352B (en) 1987-08-05
FR2571962A1 (fr) 1986-04-25
ZA858184B (en) 1987-06-24
DE3536560A1 (de) 1986-04-24

Similar Documents

Publication Publication Date Title
FI851177A0 (fi) Antivirala pyridazinaminer.
FI94340C (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
SE8800731L (sv) Fenylkarbamat
GB1285038A (en) Alkanolamine derivatives
BE879973A (fr) Electrolyte acide d'etamage
IT8320723A0 (it) Composto dell'acido fosfinilmetilamminocarbonilimminico.
AU2232288A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides
BE1002427A3 (fr) Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament.
GB1508772A (en) Biologically active compositions
IT7927962A0 (it) Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico.
KR900701763A (ko) 1-아미노-5-할로게노우라실, 그의 제조방법 및 이 화합물을 유효성분으로 함유하는 중추신경억제제
IT7927024A0 (it) Procedimento per la preparazione di n-fenil-n'-alchilfenilendiammine.
IT8621828A0 (it) Oftalmiche. sale di lisina dell'acido 4-bifenilacetico e sue composizioni
ES2017633B3 (es) Amido derivados.
IT8521765A0 (it) Tensioattivi derivati dall'acido succinico.
EP0008950A3 (fr) Dérivés de pyrimido(1,6-a)indole et intermédiaires, procédés pour leur préparation et compositions pharmaceutiques les contenant
IT7927041A0 (it) Procedimento per prevenire l'imbrattamento di elettrodi.
ATE59528T1 (de) Pestizide zusammensetzungen.
IT1114497B (it) Dispositivo e composizione per la determinazione dell'acido urico
KR850005435A (ko) 3-알콕시-2-(n-피롤리디노)-n-피리미디닐-또는 n-피라지닐 프로필아민의 제조방법
IT8025153A0 (it) Procedimento per la preparazione di acilidrazoni dell'estere dell'acido formilacetico.
KR900012884A (ko) (+)1-[(3,4,5-트리메톡시)-벤질옥시메틸]-1-페닐-N,N-디메틸-n-프로필아민, 그의 제조방법 및 치료학적 용도
ES8504736A1 (es) Un procedimiento para la preparacion de compuestos de imidazolilpropanol opticamente activos
IT8222593A0 (it) Procedimento di preparazione dell'erbicida phenmedipham.
KR870007900A (ko) 태트라 사이클릭 퀴나졸리논 및 그의 제조방법

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19871031